Recent News

• 03.31.2026 - Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
• 03.30.2026 - Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.30.2026 - Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth
• 03.05.2026 - Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum
• 02.24.2026 - Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook
• 02.24.2026 - Inogen Announces $30 Million Share Repurchase Program
• 01.12.2026 - Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025

Recent Filings

• 03.27.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 02.27.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.24.2026 - 8-K Current report